Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
94.27 CHF | -0.24% | +3.34% | +11.09% |
09:16am | Novartis and others face Italy antitrust probe over eye drug | RE |
05/06 | Cytokinetics CEO Says Board Would Have Backed Actionable Buyout | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.09% | 22TCr | |
+42.69% | 75TCr | |
+38.95% | 61TCr | |
-6.87% | 35TCr | |
+18.74% | 33TCr | |
+6.76% | 29TCr | |
+18.70% | 25TCr | |
-2.45% | 21TCr | |
+2.64% | 17TCr | |
+6.72% | 16TCr |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis Says Sandoz's Prolia, Xgeva Biosimilar Accepted for Review in US